Form 8-K - Current report:
SEC Accession No. 0001193125-22-022446
Filing Date
2022-01-31
Accepted
2022-01-31 08:27:07
Documents
13
Period of Report
2022-01-31
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d275834d8k.htm   iXBRL 8-K 40651
  Complete submission text file 0001193125-22-022446.txt   253226

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA lly-20220131.xsd EX-101.SCH 6150
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lly-20220131_def.xml EX-101.DEF 16819
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lly-20220131_lab.xml EX-101.LAB 29108
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lly-20220131_pre.xml EX-101.PRE 18365
7 EXTRACTED XBRL INSTANCE DOCUMENT d275834d8k_htm.xml XML 15844
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

EIN.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06351 | Film No.: 22571436
SIC: 2834 Pharmaceutical Preparations